FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000761749> ?p ?o ?g. }

• W2000761749 endingPage "2090" @default.
• W2000761749 startingPage "2083" @default.
• W2000761749 abstract "Background Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We assessed whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral, can reduce HIV transmission in injecting drug users. Methods In this randomised, double-blind, placebo-controlled trial, we enrolled volunteers from 17 drug-treatment clinics in Bangkok, Thailand. Participants were eligible if they were aged 20–60 years, were HIV-negative, and reported injecting drugs during the previous year. We randomly assigned participants (1:1; blocks of four) to either tenofovir or placebo using a computer-generated randomisation sequence. Participants chose either daily directly observed treatment or monthly visits and could switch at monthly visits. Participants received monthly HIV testing and individualised risk-reduction and adherence counselling, blood safety assessments every 3 months, and were offered condoms and methadone treatment. The primary efficacy endpoint was HIV infection, analysed by modified intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00119106. Findings Between June 9, 2005, and July 22, 2010, we enrolled 2413 participants, assigning 1204 to tenofovir and 1209 to placebo. Two participants had HIV at enrolment and 50 became infected during follow-up: 17 in the tenofovir group (an incidence of 0·35 per 100 person-years) and 33 in the placebo group (0·68 per 100 person-years), indicating a 48·9% reduction in HIV incidence (95% CI 9·6–72·2; p=0·01). The occurrence of serious adverse events was much the same between the two groups (p=0·35). Nausea was more common in participants in the tenofovir group than in the placebo group (p=0·002). Interpretation In this study, daily oral tenofovir reduced the risk of HIV infection in people who inject drugs. Pre-exposure prophylaxis with tenofovir can now be considered for use as part of an HIV prevention package for people who inject drugs. Funding US Centers for Disease Control and Prevention and the Bangkok Metropolitan Administration." @default.
• W2000761749 created "2016-06-24" @default.
• W2000761749 creator A5003447019 @default.
• W2000761749 creator A5016209745 @default.
• W2000761749 creator A5027427165 @default.
• W2000761749 creator A5027863249 @default.
• W2000761749 creator A5031321809 @default.
• W2000761749 creator A5048392922 @default.
• W2000761749 creator A5053567182 @default.
• W2000761749 creator A5053870577 @default.
• W2000761749 creator A5055157932 @default.
• W2000761749 creator A5066933058 @default.
• W2000761749 creator A5068546419 @default.
• W2000761749 creator A5069447013 @default.
• W2000761749 creator A5069895476 @default.
• W2000761749 creator A5070689359 @default.
• W2000761749 creator A5072330537 @default.
• W2000761749 creator A5080397703 @default.
• W2000761749 creator A5087093717 @default.
• W2000761749 date "2013-06-01" @default.
• W2000761749 modified "2023-10-12" @default.
• W2000761749 title "Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
• W2000761749 cites W1993674716 @default.
• W2000761749 cites W1995428358 @default.
• W2000761749 cites W2000485490 @default.
• W2000761749 cites W2010559555 @default.
• W2000761749 cites W2046348452 @default.
• W2000761749 cites W2049134317 @default.
• W2000761749 cites W2059707463 @default.
• W2000761749 cites W2061521317 @default.
• W2000761749 cites W2073748481 @default.
• W2000761749 cites W2095844669 @default.
• W2000761749 cites W2097057569 @default.
• W2000761749 cites W2101365779 @default.
• W2000761749 cites W2103920597 @default.
• W2000761749 cites W2116605213 @default.
• W2000761749 cites W2117057469 @default.
• W2000761749 cites W2132977017 @default.
• W2000761749 cites W2152640863 @default.
• W2000761749 cites W2162226934 @default.
• W2000761749 cites W2162761942 @default.
• W2000761749 cites W2164279718 @default.
• W2000761749 cites W2168251450 @default.
• W2000761749 cites W2316970929 @default.
• W2000761749 cites W2329960468 @default.
• W2000761749 cites W4236040230 @default.
• W2000761749 cites W4242589154 @default.
• W2000761749 doi "https://doi.org/10.1016/s0140-6736(13)61127-7" @default.
• W2000761749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23769234" @default.
• W2000761749 hasPublicationYear "2013" @default.
• W2000761749 type Work @default.
• W2000761749 sameAs 2000761749 @default.
• W2000761749 citedByCount "1169" @default.
• W2000761749 countsByYear W20007617492013 @default.
• W2000761749 countsByYear W20007617492014 @default.
• W2000761749 countsByYear W20007617492015 @default.
• W2000761749 countsByYear W20007617492016 @default.
• W2000761749 countsByYear W20007617492017 @default.
• W2000761749 countsByYear W20007617492018 @default.
• W2000761749 countsByYear W20007617492019 @default.
• W2000761749 countsByYear W20007617492020 @default.
• W2000761749 countsByYear W20007617492021 @default.
• W2000761749 countsByYear W20007617492022 @default.
• W2000761749 countsByYear W20007617492023 @default.
• W2000761749 crossrefType "journal-article" @default.
• W2000761749 hasAuthorship W2000761749A5003447019 @default.
• W2000761749 hasAuthorship W2000761749A5016209745 @default.
• W2000761749 hasAuthorship W2000761749A5027427165 @default.
• W2000761749 hasAuthorship W2000761749A5027863249 @default.
• W2000761749 hasAuthorship W2000761749A5031321809 @default.
• W2000761749 hasAuthorship W2000761749A5048392922 @default.
• W2000761749 hasAuthorship W2000761749A5053567182 @default.
• W2000761749 hasAuthorship W2000761749A5053870577 @default.
• W2000761749 hasAuthorship W2000761749A5055157932 @default.
• W2000761749 hasAuthorship W2000761749A5066933058 @default.
• W2000761749 hasAuthorship W2000761749A5068546419 @default.
• W2000761749 hasAuthorship W2000761749A5069447013 @default.
• W2000761749 hasAuthorship W2000761749A5069895476 @default.
• W2000761749 hasAuthorship W2000761749A5070689359 @default.
• W2000761749 hasAuthorship W2000761749A5072330537 @default.
• W2000761749 hasAuthorship W2000761749A5080397703 @default.
• W2000761749 hasAuthorship W2000761749A5087093717 @default.
• W2000761749 hasConcept C120665830 @default.
• W2000761749 hasConcept C121332964 @default.
• W2000761749 hasConcept C126322002 @default.
• W2000761749 hasConcept C142724271 @default.
• W2000761749 hasConcept C168563851 @default.
• W2000761749 hasConcept C197934379 @default.
• W2000761749 hasConcept C203014093 @default.
• W2000761749 hasConcept C204787440 @default.
• W2000761749 hasConcept C27081682 @default.
• W2000761749 hasConcept C2776939746 @default.
• W2000761749 hasConcept C2776983459 @default.
• W2000761749 hasConcept C2779496540 @default.
• W2000761749 hasConcept C2780580376 @default.
• W2000761749 hasConcept C3013748606 @default.
• W2000761749 hasConcept C61511704 @default.
• W2000761749 hasConcept C71924100 @default.

• next